**12. Summarizing prominent publications on tocilizumab related to COVID treatment**

Apart from several clinical research outcomes (summarized in **Table 1**) there has been several publications revealing scientific information on the mechanism, application and prospect of the drug candidate Tocilizumab for COVID-19 treatment. There are more than 30 publications found in PubMed (https://pubmed.ncbi. nlm.nih.gov/) in the year 2021 among which few significant ones are summarized in following **Table 3**.









**30**










**Table 1.** *Update of the status of clinical trials for the use of tocilizumab in the treatment of COVID-19.*
